TRIFAMOX

This brand name is authorized in Brazil, Ecuador, Mexico

Active ingredients

The drug TRIFAMOX contains a combination of these active pharmaceutical ingredients (APIs):

1 Amoxicillin UNII 804826J2HU - AMOXICILLIN

Amoxicillin is a semisynthetic penicillin (beta-lactam antibiotic) that inhibits one or more enzymes (often referred to as penicillin-binding proteins, PBPs) in the biosynthetic pathway of bactericidal peptidoglycan, which is an integral structural component of the bacterial cell wall. Inhibition of peptidoglycan synthesis leads to weakening of the cell wall, which is usually followed by cell lysis and death. Read about Amoxicillin

2 Sulbactam UNII S4TF6I2330 - SULBACTAM

Read about Sulbactam

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
J01CR02	Amoxicillin and enzyme inhibitor	J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01C Beta-lactam antibacterials, penicillins → J01CR Combinations of penicillins, incl. beta-lactamase inhibitors
Discover more medicines within J01CR02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 536500802133319, 536500803156312, 536500804152310, 536500808131318, 536500809111310
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 18.053-2-12-04, 23.735-1-05-11, 23.736-1-05-11, 23.833-1-04-11, 28305-1-11-07, 29709-1-03-11
Country: MX	Comisión Federal para la Protección contra Riesgos Sanitarios	Identifier(s): 174M98, 296M2001, 328M99, 339M99, 383M2001